Amplitude Surgical Valuation

Is AMPLI undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of AMPLI when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate AMPLI's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate AMPLI's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for AMPLI?

Key metric: As AMPLI is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for AMPLI. This is calculated by dividing AMPLI's market cap by their current earnings.
What is AMPLI's PE Ratio?
PE Ratio	98.6x
Earnings	€1.53m
Market Cap	€150.63m

AMPLI key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	2.3x
Enterprise Value/EBITDA	10.2x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does AMPLI's PE Ratio compare to its peers?

The above table shows the PE ratio for AMPLI vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	25x
ALKLH Klea Holding	32.3x	n/a	€52.9m
ALTER Theradiag	39x	n/a	€16.4m
ALEMG Laboratoires Euromedis Société anonyme	0.7x	-90.1%	€13.3m
BIM bioMérieux	28x	13.6%	€11.5b
AMPLI Amplitude Surgical	98.6x	n/a	€150.6m

Price-To-Earnings vs Peers: AMPLI is expensive based on its Price-To-Earnings Ratio (98.6x) compared to the peer average (25x).

Price to Earnings Ratio vs Industry

How does AMPLI's PE Ratio compare vs other companies in the European Medical Equipment Industry?

3 Companies	Price / Earnings	Estimated Growth	Market Cap

3 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: AMPLI is expensive based on its Price-To-Earnings Ratio (98.6x) compared to the European Medical Equipment industry average (29.7x).

Price to Earnings Ratio vs Fair Ratio

What is AMPLI's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

AMPLI PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	98.6x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate AMPLI's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Equasens Société anonyme

€628.3m

Provides healthcare IT solutions in Europe.

EQS

€41.80

-8.2%

-28.3%

Laboratoires Euromedis Société anonyme

€13.3m

Through its subsidiaries, designs, manufactures, and distributes medical equipment under the Euromedis brand name for healthcare professionals, local communities, and individuals in France and internationally.

ALEMG

€4.66

-10.4%

-3.7%

emeis Société anonyme

€983.6m

Operates nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals, and psychiatric hospitals.

EMEIS

€6.11

-5.3%

-98.5%